Sustained response of graft-versus-host disease-associated angiomatosis treated with propranolol

Clin Exp Dermatol. 2018 Dec;43(8):962-964. doi: 10.1111/ced.13540. Epub 2018 May 13.

Authors

A D Kidambi¹, B Mathew², M Goodfield¹, P M Laws¹

Affiliations

¹ Department of Dermatology, Chapel Allerton Hospital (Leeds Teaching Hospital), Leeds, West Yorkshire, UK.
² Department of Histopathology, St James's University Hospital, Beckett Street, Leeds, West Yorkshire, UK.

PMID: 29756271
DOI: 10.1111/ced.13540

No abstract available

Publication types

Case Reports

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Angiomatosis / drug therapy*
Angiomatosis / etiology
Female
Graft vs Host Disease / complications*
Humans
Middle Aged
Propranolol / therapeutic use*
Skin Diseases / drug therapy*
Skin Diseases / etiology

Substances

Adrenergic beta-Antagonists
Propranolol